Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development...
Hence then, the article about pleopharma to present newdata on cannabis withdrawal in patients with cannabis use disorder and phase 2 pp 01 results at the college on problems of drug dependence 88th annual scientific meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING )
Also on site :
- HDFC Bank Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HDB
- Quote of the Day: Cleanthes Worked Night Shifts as a Water Carrier to Study Philosophy by Day. Then He Took Over Ancient Greece’s Leading Stoic School
- Anne Hathaway Will Campaign This Awards Season in an Unexpected Category, 13 Years After Her Oscar Win